Gong, W., Liu, Y., Seidl, C., Diamandis, E. P., Kiechle, M., Drecoll, E., . . . Dorn, J. (2019). Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. BMC cancer, 19(1), 696-9. https://doi.org/10.1186/s12885-019-5901-0
Chicago-Zitierstil (17. Ausg.)Gong, Weiwei, Yueyang Liu, Christof Seidl, Eleftherios P. Diamandis, Marion Kiechle, Enken Drecoll, Matthias Kotzsch, Viktor Magdolen, und Julia Dorn. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer 19, no. 1 (2019): 696-9. https://doi.org/10.1186/s12885-019-5901-0.
MLA-Zitierstil (9. Ausg.)Gong, Weiwei, et al. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer, vol. 19, no. 1, 2019, pp. 696-9, https://doi.org/10.1186/s12885-019-5901-0.